Tetrandrine alleviates atherosclerosis via inhibition of STING-TBK1 pathway and inflammation in macrophages
- 24 April 2023
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 119, 110139
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81930108, 81970323, 82271347)
This publication has 42 references indexed in Scilit:
- Tetrandrine suppresses articular inflammatory response by inhibiting pro‐inflammatory factors via NF‐κB inactivationJournal of Orthopaedic Research, 2016
- Anti-inflammatory therapies for atherosclerosisNature Reviews Cardiology, 2015
- Vascular fibrosis in atherosclerosisCardiovascular Pathology, 2013
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic AcidThe Journal of Immunology, 2013
- Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-κB activationImmunology Letters, 2008
- Signaling to NF-κB by Toll-like receptorsTrends in Molecular Medicine, 2007
- Role of Endothelial Dysfunction in AtherosclerosisCirculation, 2004
- Inflammation and AtherosclerosisCirculation, 2002
- Intraperitoneal Administration of Anti–c- fms Monoclonal Antibody Prevents Initial Events of Atherogenesis but Does Not Reduce the Size of Advanced Lesions in Apolipoprotein E–Deficient MiceCirculation, 1999
- Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosisHistopathology, 1990